Chinese Expert Consensus on the Clinical Application of Photobiomodulation Therapy in Dermatology (2025)

Photobiomodulation therapy (PBMT) is a safe and effective option for multiple skin diseases. To promote standardized clinical use, this expert consensus was developed by 35 dermatology experts through 2 rounds of Delphi surveys and addressed 19 clinical questions with a consensus degree of over 80.0%. This consensus summarizes current evidence on PBMT’s mechanisms of action, indications, contraindications, treatment parameters, and adverse event management. Although encouraging outcomes have been observed regarding acne vulgaris, photoaging, alopecia, and other dermatologic conditions, considerable variability in treatment protocols and the scarcity of high-quality, large-scale clinical trials continue to limit broader clinical adoption. This consensus provides evidence-based and practical guidance to support the safe and effective incorporation of PBMT into dermatologic practice in China.

Authors

Institutions

Publication Details

Journal
International Journal of Dermatology and Venereology
Published
2026-01-14
DOI
https://doi.org/10.1097/jd9.0000000000000456
Primary Topic
Dermatologic Treatments and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chinese Expert Consensus on the Clinical Application of Photobiomodulation Therapy in Dermatology (2025)

Yan Ding, Y E Liu, Yiping Ge, Qi Li et al.
International Journal of Dermatology and Venereology
Dermatologic Treatments and Research
article

Chinese Expert Consensus on the Clinical Application of Photobiomodulation Therapy in Dermatology (2025)

Yan Ding, Y E Liu, Yiping Ge, Qi Li, Jiayi Liu, Xiuli Wang, Xiaoying Chen, Yi Jin, Meifang Wang, Yanyan Feng, Weihui Zeng, Xiangning Qiu, Tian-Hua Xu, Jin Chen, Zhikuan Xia, Lili Shao, Z Lu, Dan Jian, X L Wen, Zhe Jian, Fang Xiang, Fang Fang, Bing-Xue Bo, Yan Wu, Zhi Yang, Li Li, Rui Yin, Xue-Li Li, Xiao-Fei Mao, Xian Jiang, Yue-Lan Cao, Bo Yu, Hua-Xu Liu, Yan Li
article en

Abstract

Photobiomodulation therapy (PBMT) is a safe and effective option for multiple skin diseases. To promote standardized clinical use, this expert consensus was developed by 35 dermatology experts through 2 rounds of Delphi surveys and addressed 19 clinical questions with a consensus degree of over 80.0%. This consensus summarizes current evidence on PBMT’s mechanisms of action, indications, contraindications, treatment parameters, and adverse event management. Although encouraging outcomes have been observed regarding acne vulgaris, photoaging, alopecia, and other dermatologic conditions, considerable variability in treatment protocols and the scarcity of high-quality, large-scale clinical trials continue to limit broader clinical adoption. This consensus provides evidence-based and practical guidance to support the safe and effective incorporation of PBMT into dermatologic practice in China.

International Journal of Dermatology and VenereologyVol. 9(1)
Fujian Medical University (CN), Union Hospital (HK), Central South University (CN), Army Medical University (CN), Harbin Medical University (CN), Guangxi Medical University (CN), Capital Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Peking University (CN), Sichuan University (CN), Fudan University (CN), Kunming Medical University (CN), China-Japan Friendship Hospital (CN), Peking Union Medical College Hospital (CN), Ruijin Hospital (CN), Tianjin Medical University General Hospital (CN), Chinese PLA General Hospital (CN), Haikou City People's Hospital (CN), West China Second University Hospital of Sichuan University (CN), Shandong Provincial Institute of Dermatology and Venereology (CN), West China Hospital of Sichuan University (CN), Shenzhen Sixth People's Hospital (CN), Shanghai Changzheng Hospital (CN), ShenZhen People’s Hospital (CN), Chinese Academy of Medical Sciences Dermatology Hospital (CN), First Affiliated Hospital of Kunming Medical University (CN), First Affiliated Hospital of Fujian Medical University (CN), People's Hospital of Xinjiang Uygur Autonomous Region (CN), First Affiliated Hospital of GuangXi Medical University (CN), Hainan General Hospital (CN), Peking University Shenzhen Hospital (CN), The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), General Hospital of Shenyang Military Region (CN), Peking University First Hospital (CN), Southwest Hospital (CN), Second Affiliated Hospital of Xi'an Jiaotong University (CN), Second Affiliated Hospital of Harbin Medical University (CN), Chengdu Second People's Hospital (CN), Henan Provincial People's Hospital (CN), Beijing Children’s Hospital (CN), Shanghai Institute of Hematology (CN), Beijing Friendship Hospital (CN), Second Xiangya Hospital of Central South University (CN), Shanghai Skin Disease Hospital (CN), Second Affiliated Hospital of Zhejiang University (CN), Xijing Hospital (CN), Huashan Hospital (CN), Xiangya Hospital Central South University (CN), Shandong First Medical University (CN), Anshan Hospital (CN), Huazhong University of Science and Technology (CN), Chongqing Medical University (CN), China Medical University (CN)
Good health and well-being
Openalex Percentile: Top 88%
Dermatologic Treatments and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.